Pharmacokinetic (PK) interaction of fixed-dose combination (FDC) antiretrovirals (ARV) with riociguat (rio)

E. Dejesus (Florida, United States of America), S. Saleh (Wuppertal, Germany), D. Van Der Mey (Wuppertal, Germany), C. Becker (Wuppertal, Germany), R. Frey (Wuppertal, Germany), S. Unger (Wuppertal, Germany), W. Mueck (Wuppertal, Germany)

Source: International Congress 2018 – Pulmonary hypertension: therapy
Session: Pulmonary hypertension: therapy
Session type: Thematic Poster
Number: 3036
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Dejesus (Florida, United States of America), S. Saleh (Wuppertal, Germany), D. Van Der Mey (Wuppertal, Germany), C. Becker (Wuppertal, Germany), R. Frey (Wuppertal, Germany), S. Unger (Wuppertal, Germany), W. Mueck (Wuppertal, Germany). Pharmacokinetic (PK) interaction of fixed-dose combination (FDC) antiretrovirals (ARV) with riociguat (rio). 3036

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: